Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Tracy M Saxton
AddedFeb 15, 2024
UpdatedMay 31, 2026
Tracy M Saxton

Tracy M Saxton

Co-Founder, Pivotal bioVenture Partners

CrunchbaseLinkedIn

Tracy M Saxton's Career

Pivotal bioVenture Partners
Pivotal bioVenture Partners

San Francisco, CA, US

Co-Founder
PanOptica
PanOptica

Mount Arlington, NJ, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Tracy M Saxton's Career

Pivotal bioVenture Partners
Pivotal bioVenture Partners
Investment FirmInvestment Firm172017San Francisco, CA, US
Co-Founder

Leadership at Pivotal bioVenture Partners

Ash KhannaAsh KhannaBoard Member
Vincent CheungVincent CheungCo-Founder

Similar to Pivotal bioVenture Partners

Pivotal bioVenture Partners ChinaPivotal bioVenture Partners ChinaShanghai, Shanghai, CNest. 2017Pivotal bioVenture Partners ChinaShanghai, Shanghai, CN · est. 2017

Pivotal bioVenture Partners China: A venture capital firm innovating in life sciences.

Investment Firm7
Nan Fung Life SciencesNan Fung Life SciencesSan Francisco, CA, USest. 2017Nan Fung Life SciencesSan Francisco, CA, US · est. 2017

Nan Fung Life Sciences: A global investment platform specializing in life sciences sector.

Investment Firm30
LifeSci Venture PartnersLifeSci Venture PartnersNew York City, NY, USest. 2017LifeSci Venture PartnersNew York City, NY, US · est. 2017

LifeSci Venture Partners, formed in 2017, is an early-stage investment firm in life sciences and healthcare.

Investment Firm5
Avalon BioVenturesAvalon BioVenturesLos Angeles, CA, USest. 2013Avalon BioVenturesLos Angeles, CA, US · est. 2013

Avalon BioVentures: A biotech venture capital firm advancing breakthrough therapeutics.

Investment Firm4
PanOptica
PanOptica
Acquired$109.9M02009Mount Arlington, NJ, US
Board Member· Board

Leadership at PanOptica

Thomas DyrbergThomas DyrbergBoard Member
Kevin StarrKevin StarrBoard Member
Colin GoddardColin GoddardBoard Member
Paul ChaneyPaul ChaneyBoard Member
David GuyerDavid GuyerBoard Member
Bruce PeacockBruce PeacockBoard Member

Similar to PanOptica

Hyperion DeFiHyperion DeFiNew York City, NY, USTherapeuticsest. 2014Hyperion DeFiNew York City, NY, US · est. 2014

Eyenovia, Inc.: A NASDAQ-listed biopharmaceutical firm innovating advanced ophthalmic therapeutics.

Public · $75.1M41
Ocular TherapeutixOcular TherapeutixBedford, MA, USOphthalmic Therapiesest. 2006Ocular TherapeutixBedford, MA, US · est. 2006

Ocular Therapeutix, Inc.: Global biopharma innovator in hydrogel-based ophthalmic therapies.

Public · $386.5M274
EyeCyteEyeCyteLos Angeles, CA, USTherapeuticsest. 2005EyeCyteLos Angeles, CA, US · est. 2005

EyeCyte: Developing novel therapeutics for neovascular and degenerative retinal diseases.

Series A · $3M5
VisioxVisioxTarrytown, NY, USTherapeuticsest. 2022VisioxTarrytown, NY, US · est. 2022

Visiox: A privately-funded biopharmaceutical firm innovating new treatments for prevalent ophthalmic diseases.

Seed · $7M7

Tracy M Saxton's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to Tracy M Saxton

Jeni LeeJeni LeeCo-Founder · Vivita TechnologiesJohn SageJohn SageCEO · Pivotal VenturesSarah SclarsicSarah SclarsicCo-Founder · Voyager VenturesJONATHAN MARC CAPLISJONATHAN MARC CAPLISFounder · PivotalPathBrad PhaisanBrad PhaisanFounder & CEO · OmniVirtChris WilliamsChris WilliamsCo-Founder · Chromaom